DK2627386T3 - Næsesprayindretning - Google Patents

Næsesprayindretning Download PDF

Info

Publication number
DK2627386T3
DK2627386T3 DK11779089.9T DK11779089T DK2627386T3 DK 2627386 T3 DK2627386 T3 DK 2627386T3 DK 11779089 T DK11779089 T DK 11779089T DK 2627386 T3 DK2627386 T3 DK 2627386T3
Authority
DK
Denmark
Prior art keywords
nasal spray
discharge orifice
spray device
pharmaceutical formulation
transfer channel
Prior art date
Application number
DK11779089.9T
Other languages
English (en)
Inventor
Declan Walsh
Xian-Ming Zeng
Jade Ly
Armando Morales
Original Assignee
Ivax Pharmaceuticals Ireland
Teva Branded Pharmaceutical Prod R & D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2627386(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ivax Pharmaceuticals Ireland, Teva Branded Pharmaceutical Prod R & D Inc filed Critical Ivax Pharmaceuticals Ireland
Application granted granted Critical
Publication of DK2627386T3 publication Critical patent/DK2627386T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
    • B65D83/44Valves specially adapted therefor; Regulating devices
    • B65D83/52Valves specially adapted therefor; Regulating devices for metering
    • B65D83/54Metering valves ; Metering valve assemblies

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Massaging Devices (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Claims (10)

1. Næsesprayindretning (1) til levering afen farmaceutisk formulering til næsehulen i afmålte doser, indretningen omfattende: en tryksat aerosolbeholder (3) som inkluderer en ampul (4) indeholdende en farmaceutisk formulering omfattende en aktiv ingrediens, et drivmiddel og, eventuelt, et cosolvent, aerosolbeholderen (3) endvidere inkluderende en kalibreringsventil (6) som har en ventilspindel (8); og en aktuator (2) til aerosolbeholderen (3), aktuatoren (2) inkluderende en spindelblok (11) som har en beholder i hvilken ventilspindlen (8) af kalibreringsventilen (6) af aerosolbeholderen (3) er modtaget og aksialt placeret og som kan forskydes i forhold til ampullen (4) af aerosolbeholderen (3) for at aktivere kalibreringsventilen (6) af aerosolbeholderen (3), et bundkar (15) som strækker sig under beholderen, spindelblokken (11) definerer endvidere en udledningsmunding (19) til den farmaceutiske formulering og en overførselskanal (13) igennem hvilken en dispenseret dosis af den farmaceutiske formulering er i stand til at passere fra bundkarret (15) til udledningsmundingen (19), hvor aktuatoren (2) endvidere omfatter et leveringsudløb (12) til en aerosolsky, hvor udledningsmundingen (19) er anbragt til at rette aerosolskyen igennem leveringsudløbet (12), kendetegnet ved at indretningen (1) er indrettet til at producere en aerosolsky for en dispenseret dosis som har en spray kraftværd i ikke større end 40 mN målt ved en afstand på 30 mm fra udledningsmundingen (19), hvor udledningsmundingen (19) haren diameter fra 0,15 til 0,65 mm og en længde fra 0,5 til 1,0 mm, og overførselskanalen (13) har en længde på 3 til 20 mm.
2. Næsesprayindretning ifølge krav 1, hvor en maksimal transversal dimension af overførselskanalen (13) er større end en diameter af udledningsmundingen (19).
3. Næsesprayindretning ifølge krav 1, hvor en maksimal tværgående dimension af overførselskanalen (13) er fra 1,0 til 3,0 mm.
4. Næsesprayindretning ifølge krav 1, hvor overførselskanalen (13) haret cirkulært tværsnit.
5. Næsesprayindretning ifølge krav 1, hvor overførselskanalen (13) har en tværgående dimension som tilspidser ned mod en ende af udledningsmundingen (19).
6. Næsesprayindretning ifølge krav 1, hvor overførselskanalen (13) har en første del i fluid forbindelse med bundkarret (15) af spindelblokken (11) og en anden del i fluid forbindelse med udledningsmundingen (19), hvor den anden del og udledningsmundingen (19) er defineret af en separat indsats modtaget i en åbning formet i spindelblokken (11) af aktuatoren (2).
7. Næsesprayindretning ifølge krav 1, hvor cosolventet er til stede i 0,5 til 20 vægtprocent, baseret på en samlet vægt af den farmaceutiske formulering.
8. Næsesprayindretning ifølge krav 1, hvor den aktive ingrediens er beclometason dipropionat, drivmidlet er valgt fra P134a, P227 eller blandinger deraf, eller andre tryksatte gasser, og cosolventet er til stede og er vandfrit ethanol.
9. Næsesprayindretning ifølge krav 1, hvor den farmaceutiske formulering er en opløsningsformulering.
10. Næsesprayindretning ifølge krav 1, hvor den farmaceutiske formulering er en suspensionsformulering.
DK11779089.9T 2010-10-12 2011-10-12 Næsesprayindretning DK2627386T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39222310P 2010-10-12 2010-10-12
PCT/EP2011/005118 WO2012048867A1 (en) 2010-10-12 2011-10-12 Nasal spray device

Publications (1)

Publication Number Publication Date
DK2627386T3 true DK2627386T3 (da) 2015-05-26

Family

ID=44907783

Family Applications (2)

Application Number Title Priority Date Filing Date
DK15164095.0T DK2926855T3 (da) 2010-10-12 2011-10-12 Næsesprayanordning
DK11779089.9T DK2627386T3 (da) 2010-10-12 2011-10-12 Næsesprayindretning

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK15164095.0T DK2926855T3 (da) 2010-10-12 2011-10-12 Næsesprayanordning

Country Status (30)

Country Link
US (2) US20120085345A1 (da)
EP (2) EP2627386B1 (da)
JP (2) JP6050236B2 (da)
KR (1) KR101559639B1 (da)
CN (3) CN106178205A (da)
AU (1) AU2011316124B2 (da)
BR (1) BR112013008824A2 (da)
CA (1) CA2814212C (da)
CL (1) CL2013000958A1 (da)
CY (1) CY1121719T1 (da)
DK (2) DK2926855T3 (da)
EA (1) EA023795B1 (da)
ES (2) ES2536969T3 (da)
HK (1) HK1214990A1 (da)
HR (2) HRP20150452T1 (da)
HU (1) HUE043276T2 (da)
IL (1) IL225712A (da)
LT (1) LT2926855T (da)
MX (1) MX336164B (da)
NZ (1) NZ608218A (da)
PE (1) PE20131492A1 (da)
PL (2) PL2926855T3 (da)
PT (2) PT2627386E (da)
RS (2) RS58574B1 (da)
SG (1) SG189892A1 (da)
SI (2) SI2926855T1 (da)
SM (1) SMT201500114B (da)
TR (1) TR201902415T4 (da)
WO (1) WO2012048867A1 (da)
ZA (1) ZA201301938B (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201121812D0 (en) * 2011-12-07 2012-02-01 Teva Branded Pharmaceutical Prod R & D Inc NAsal formulation
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EP2890437B1 (en) * 2012-08-29 2019-12-18 Chiesi Farmaceutici S.p.A. Aerosol inhalation device
GB201308679D0 (en) * 2013-05-14 2013-06-26 3M Innovative Properties Co Actuator for an inhaler
CN103550058B (zh) * 2013-11-21 2015-08-19 江门大诚医疗器械有限公司 一种加氧清创器
GB201322677D0 (en) * 2013-12-20 2014-02-05 3M Innovative Properties Co Actuator for an inhaler
GB201408229D0 (en) * 2014-05-09 2014-06-25 Norton Waterford Ltd Aerosol device
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
WO2017008127A1 (en) * 2015-07-16 2017-01-19 Gd Pharma Pty Ltd Spray device and dosage cartridge
CN106376976B (zh) * 2016-10-13 2023-05-12 深圳市新宜康科技股份有限公司 一种单侧气道油气分离电子烟雾化器
US20190240427A1 (en) * 2016-11-06 2019-08-08 Microbase Technology Corp. Microstructured nozzle
US10556072B2 (en) * 2017-01-31 2020-02-11 Dunan Microstaq, Inc. Metering device for a metered dose inhaler
KR102140739B1 (ko) 2018-04-23 2020-08-04 충남대학교산학협력단 상기도 분무 장치
KR20200098188A (ko) 2019-02-12 2020-08-20 조민수 다기능 상기도 분무 장치
CN210123827U (zh) * 2019-05-31 2020-03-03 庆虹电子(苏州)有限公司 电连接器
WO2021247283A1 (en) * 2020-06-04 2021-12-09 Amcyte Pharma, Inc. Delivery of aerosolized micromolar composition concentrations
FR3120534B1 (fr) * 2021-03-09 2023-06-30 Aptar France Sas Tête de distribution nasale de produit fluide et dispositif comportant une telle tête
WO2024079676A1 (en) * 2022-10-12 2024-04-18 Glenmark Specialty S.A. Novel nasal spray assembling process
CN116688331B (zh) * 2023-05-29 2024-02-20 山东京卫制药有限公司 一种鼻气雾剂给药器及其方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) * 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
SE8704767L (sv) * 1987-11-30 1989-05-31 Sigmund Johannes Loefstedt Ny metod foer administrering av laekemedel
JP2922935B2 (ja) * 1989-08-11 1999-07-26 東興薬品工業株式会社 粘稠液用鼻孔内噴霧容器の使捨てアダプタ
ES2064160T3 (es) 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
GB9705657D0 (en) * 1997-03-19 1997-05-07 Bacon Raymond J Dispenser
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB0121568D0 (en) * 2001-09-06 2001-10-24 Optinose As Nasal delivery device
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
JP4472105B2 (ja) * 2000-04-20 2010-06-02 株式会社ダイゾー 噴霧製品
GB2367011A (en) * 2000-08-26 2002-03-27 Glaxo Group Ltd Metered dose inhaler for salmeterol
US20030178022A1 (en) * 2001-12-21 2003-09-25 Chiesi Farmaceutici S.P.A. Pressurized metered dose inhaler (PMDI) actuators and medicinal aerosol solution formulation products comprising therse actuators
GB0226020D0 (en) 2002-11-07 2002-12-18 Glaxo Group Ltd A holder
US7448385B2 (en) * 2004-06-07 2008-11-11 Purepharm Inc. Nasal adaptation of an oral inhaler device
US7055541B2 (en) 2004-09-07 2006-06-06 Ramot At Tel-Aviv University Ltd. Method and mechanism for producing suction and periodic excitation flow
FR2881119B1 (fr) * 2005-01-25 2010-07-30 Valois Sas Dispositif de distribution de produit fluide.
EP1792660A1 (en) * 2005-12-02 2007-06-06 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device
CN101528290A (zh) * 2006-08-22 2009-09-09 葛兰素集团有限公司 用于吸入器的致动器
WO2008023015A1 (en) * 2006-08-22 2008-02-28 Glaxo Group Limited Actuator for an inhaler
MX2009009061A (es) * 2007-02-28 2009-11-12 Abbott Respiratory Llc Sistema de atomizacion a base de boquilla.
EP2011534A1 (en) 2007-07-03 2009-01-07 CHIESI FARMACEUTICI S.p.A. Metered dose inhaler actuator
DE102007063213B3 (de) * 2007-12-20 2009-06-18 Ing. Erich Pfeiffer Gmbh Austragsvorrichtung zur nasalen Anwendung

Also Published As

Publication number Publication date
EP2926855A1 (en) 2015-10-07
EP2926855B1 (en) 2018-12-05
MX2013003840A (es) 2013-08-15
EP2627386A1 (en) 2013-08-21
TR201902415T4 (tr) 2019-03-21
JP2015147061A (ja) 2015-08-20
PT2926855T (pt) 2019-02-27
EA201390490A1 (ru) 2013-07-30
BR112013008824A2 (pt) 2016-06-28
CN106178206A (zh) 2016-12-07
NZ608218A (en) 2014-10-31
CA2814212C (en) 2015-06-02
PT2627386E (pt) 2015-06-11
WO2012048867A1 (en) 2012-04-19
JP2013541378A (ja) 2013-11-14
IL225712A0 (en) 2013-06-27
US10188811B2 (en) 2019-01-29
ES2712996T3 (es) 2019-05-17
US20160082204A1 (en) 2016-03-24
CY1121719T1 (el) 2020-07-31
JP6023247B2 (ja) 2016-11-09
ZA201301938B (en) 2014-05-28
RS58574B1 (sr) 2019-05-31
HRP20150452T1 (hr) 2015-08-14
AU2011316124B2 (en) 2014-12-11
JP6050236B2 (ja) 2016-12-21
SMT201500114B (it) 2015-09-07
CL2013000958A1 (es) 2014-05-30
CA2814212A1 (en) 2012-04-19
RS54037B1 (en) 2015-10-30
PL2627386T3 (pl) 2015-08-31
EP2627386B1 (en) 2015-04-22
AU2011316124A1 (en) 2013-04-04
SG189892A1 (en) 2013-06-28
DK2926855T3 (da) 2019-03-25
CN106178205A (zh) 2016-12-07
IL225712A (en) 2017-07-31
HRP20190337T1 (hr) 2019-05-03
PL2926855T3 (pl) 2019-06-28
SI2627386T1 (sl) 2015-10-30
KR20130100334A (ko) 2013-09-10
KR101559639B1 (ko) 2015-10-12
HUE043276T2 (hu) 2019-08-28
HK1214990A1 (zh) 2016-08-12
PE20131492A1 (es) 2014-01-17
CN103282070B (zh) 2016-08-10
MX336164B (es) 2016-01-11
US20120085345A1 (en) 2012-04-12
ES2536969T3 (es) 2015-06-01
LT2926855T (lt) 2019-03-25
CN103282070A (zh) 2013-09-04
SI2926855T1 (sl) 2019-05-31
EA023795B1 (ru) 2016-07-29

Similar Documents

Publication Publication Date Title
DK2627386T3 (da) Næsesprayindretning
JP6283388B2 (ja) Copd用併用療法
DK3089735T3 (da) Stabil tryksat aerosolopløsningssammensætning af glycopyrroniumbromid og formoterolkombination
DK3096737T3 (da) Stabil tryksat aerosolopløsningssammensætning af glycopyrroniumbromid og formoterolkombination
JP5800829B2 (ja) Copd用エアロゾル製剤
US10960154B2 (en) Aerosol device
AU2015201102B2 (en) Nasal spray device
DK2788001T3 (da) Nasalformulering
US20230057979A1 (en) Medicinal compositions for carbon dioxide based metered dose inhalers
CN117915894A (zh) 定量吸入器和混悬液组合物
KR20220108047A (ko) 가압 정량 흡입기를 위한 스테인리스 스틸 캔
EA039998B1 (ru) Способ уменьшения частоты обострений хобл умеренной/тяжелой хобл степени